EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

BAP1 loss impairs IFN-γ signaling and enhances NK cell-mediated cytotoxicity in myeloid leukemia

Chiara Badami, Erna Islamagic, Linnea Blomén, Frida Svensson, Theebiga Kathirkamanathan, Kristoffer Hellstrand, Elin Bernson, Fredrik B Thorén

Cancer Immunology, Immunotherapy · 15.06.2026 · 75 (6)

DOI: 10.1007/s00262-026-04453-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, online erschienen am 15.06.2026. Verfasst von Chiara Badami und 7 weiteren Autor:innen. Beteiligte Einrichtung: TIMM Laboratory at Sahlgrenska Center for Cancer Research, University of Gothenburg, Box 450, 405 30, Gothenburg, Sweden. Hauptthemen laut MEDLINE: Ubiquitin Thiolesterase, Killer Cells, Natural, Interferon-gamma, Tumor Suppressor Proteins. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Cancer Society, Swedish Research Council, Swedish state via the ALF agreement.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Natural killer (NK) cells recognize and eliminate malignant cells through multiple receptor–ligand interactions. To uncover genetic determinants of the susceptibility of myeloid leukemia cells to NK cell cytotoxicity, we analyzed several genome-wide CRISPR screens. Among recurrent hits, the BRCA1-associated protein 1 ( BAP1 ) gene emerged as a key factor protecting K562 leukemic cells from NK cell-mediated killing. Using BAP1 knockout (KO) models, we found that loss of BAP1 alone did not alter NK cell sensitivity. However, upon interferon-γ (IFN-γ) stimulation, BAP1 KO K562 cells exhibited reduced HLA class I induction, triggered enhanced NK cell degranulation, and showed increased sensitivity to NK cell-mediated cytotoxicity compared with wild-type cells. Further experiments revealed that BAP1-deficient cells displayed reduced expression of the IFN-γ receptor 1 (IFN-γ-R1). BAP1 knockdown across multiple myeloid leukemia cell lines selectively decreased HLA-E and IFN-γ-R1 expression in ASXL1 -mutant backgrounds. These findings suggest that BAP1 may contribute to the regulation of IFN-γ responsiveness and immune evasion in myeloid leukemia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ubiquitin ThiolesteraseKiller Cells, NaturalInterferon-gammaTumor Suppressor ProteinsLeukemia, MyeloidCytotoxicity, ImmunologicHumansSignal TransductionK562 CellsReceptors, InterferonInterferon gamma ReceptorCell Line, Tumor

Stichwörter der Autor:innen

BAP1CRISPR/Cas9HLA-IIFN-γNK cells

Substanzen

Ubiquitin ThiolesteraseInterferon-gammaBAP1 protein, humanTumor Suppressor ProteinsReceptors, InterferonInterferon gamma Receptor

Autor:innen und Institutionen

  • TIMM Laboratory at Sahlgrenska Center for Cancer Research, University of Gothenburg, Box 450, 405 30, Gothenburg, Sweden.
  • Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Department of Obstetrics and Gynecology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • TIMM Laboratory at Sahlgrenska Center for Cancer Research, University of Gothenburg, Box 450, 405 30, Gothenburg, Sweden. fredrik.thoren@gu.se.
  • Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. fredrik.thoren@gu.se.

Förderung

  • Swedish Cancer Society
  • Swedish Research Council
  • Swedish state via the ALF agreement
  • University of Gothenburg

Zitieren

APA

Badami, C., Islamagic, E., Blomén, L., Svensson, F., Kathirkamanathan, T., Hellstrand, K., Bernson, E., & Thorén, F. B. (2026). BAP1 loss impairs IFN-γ signaling and enhances NK cell-mediated cytotoxicity in myeloid leukemia. Cancer Immunology, Immunotherapy, 75(6). https://doi.org/10.1007/s00262-026-04453-5

Vancouver

Badami C, Islamagic E, Blomén L, Svensson F, Kathirkamanathan T, Hellstrand K, et al. BAP1 loss impairs IFN-γ signaling and enhances NK cell-mediated cytotoxicity in myeloid leukemia. Cancer Immunology, Immunotherapy. 2026;75(6). doi:10.1007/s00262-026-04453-5

BibTeX
@article{Badami2026,
  author = {Badami, Chiara and Islamagic, Erna and Blomén, Linnea and Svensson, Frida and Kathirkamanathan, Theebiga and Hellstrand, Kristoffer and Bernson, Elin and Thorén, Fredrik B},
  title = {BAP1 loss impairs IFN-γ signaling and enhances NK cell-mediated cytotoxicity in myeloid leukemia},
  journal = {Cancer Immunology, Immunotherapy},
  year = {2026},
  volume = {75},
  number = {6},
  doi = {10.1007/s00262-026-04453-5}
}
Kostenlos starten →